CJC-1295 DAC 10mg — Long-acting GHRH analog research peptide with Drug Affinity Complex (CAS 863288-34-0). 6-8 day half-life. 99% purity, USA domestic. Same-day shipping. Free shipping over $200.
Original price was: $65.00.$55.00Current price is: $55.00.
Out of stock
CJC-1295 DAC 10mg is a research-grade long-acting growth hormone-releasing hormone (GHRH) analog with a Drug Affinity Complex (DAC) technology modification (CAS 863288-34-0), engineered for extended half-life GH/IGF-1 axis stimulation in pre-clinical models. The DAC modification covalently binds CJC-1295 to circulating albumin, dramatically extending its plasma half-life from minutes (native GHRH) to approximately 6–8 days — enabling sustained GH secretagogue signaling for long-duration research protocols.
CJC-1295 DAC 10mg is used in pre-clinical research settings for:
When searching for CJC-1295 DAC 10mg for sale or a reliable source to buy CJC-1295 DAC research peptide online, researchers choose Combat Research for purity and speed:
| Property | Value |
|---|---|
| CAS Number | 863288-34-0 |
| Also Known As | CJC-1295 DAC, CJC-1295 with DAC, DAC:GRF |
| Peptide Class | GHRH analog with Drug Affinity Complex |
| Half-Life | ~6-8 days (vs ~7 min native GHRH) |
| Form | Lyophilized Powder |
| Vial Size | 10mg |
| Purity | ≥99% |
| Storage | Refrigerated, protected from light and moisture |
CJC-1295 DAC uses albumin-binding technology to extend plasma half-life to 6–8 days, enabling sustained, steady GH elevation. CJC-1295 without DAC (Modified GRF 1-29) has a half-life of ~30 minutes and produces sharper, more physiological GH pulses. Researchers choose between them based on study design: sustained baseline elevation (with DAC) vs. pulsatile GH pattern research (without DAC).
CJC-1295 DAC 10mg is supplied as a lyophilized powder. Reconstitute with bacteriostatic water or sterile saline under aseptic conditions. Store refrigerated at 2–8°C. Minimize freeze-thaw cycles to preserve DAC linkage integrity.
CJC-1295 DAC (CAS 863288-34-0) is sold exclusively for pre-clinical and in vitro laboratory research. Not for human or animal consumption or therapeutic use. All use must comply with applicable local, state, and federal regulations governing research compounds.
CJC-1295 DAC (CAS 863288-34-0) is a synthetic GHRH analog modified with Drug Affinity Complex (DAC) technology that covalently binds to circulating albumin, extending plasma half-life to approximately 6-8 days. It is studied for sustained GH/IGF-1 axis stimulation in pre-clinical research.
DAC stands for Drug Affinity Complex. It is a modification that uses a maleimido-propionyl-lysine reactive group to form a covalent bond with serum albumin, dramatically extending the peptide’s plasma half-life from minutes to 6-8 days.
CJC-1295 DAC binds albumin for a 6-8 day half-life, producing sustained GH elevation. CJC-1295 without DAC (Mod GRF 1-29) has a 30-minute half-life, producing sharper GH pulses. Choice depends on whether study design requires sustained or pulsatile GH patterns.
CAS 863288-34-0. Also known as DAC:GRF and CJC-1295 with Drug Affinity Complex. Research peptide class: long-acting GHRH analog.
CJC-1295 DAC is studied for GH secretagogue pharmacokinetics, GHRH receptor activation, long-duration GH/IGF-1 axis stimulation, body composition studies, albumin-binding DAC technology pharmacology, and combination protocols with GHRP-class peptides like ipamorelin.
Reconstitute with bacteriostatic water or sterile saline under aseptic conditions. Gently swirl until dissolved. Store refrigerated at 2-8 degrees Celsius. Minimize freeze-thaw cycles to preserve DAC linkage integrity.
CJC-1295 DAC 10mg is available from Combat Research with 99% purity, USA domestic stock, same-day shipping, and free shipping on orders over .
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.